% | $
Quotes you view appear here for quick access.

Allergan plc Message Board

  • saurai saurai Jan 22, 2013 10:48 PM Flag

    MAPP aquistion is looking like a solid move. PATH is a simliar opp that is quite promising.

    I am expecting a nice move in PATH in tandem with MAPP. Take a look and see the details before the exptected runup. Again, Great move AGN!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Why didn't they make a run at ALEXA-Alreadly have FDA approval for the Staccato delivery system?

      Maybe they will still make a run at ALEXA-Would be a very inexpensive acquesition.

      Sentiment: Hold

    • I love AGN's ultra low beta. It discourages the chart guys and program traders from trying to push prices around. This is a solid growth company whose value has not been clouded by the momentum traders. I am a buyer on this pullback.

      Sentiment: Buy

    • I agree that this is a great move.
      There is so much opportunity for effective treatments in the migraine space and AGN could become a major player with Botox and MAP Pharm.'s Levadex.
      This is a solid strategic move that will pay off -- BIG time -- for AGN.
      This should make AGN an even more attractive, plus exiting stock, when you add the recent acquisition of SkinMedica, coupled with last Friday's approval of Botox for over-active bladder -- OAB.
      Management is positioning this company to lead, grow and shine for years to come.
      What a bonanza!!

230.47-2.61(-1.12%)Oct 21 4:02 PMEDT